Request an Appointment



Contact us with Questions

Expand Content

Mark Sands, MD


Mark Sands, MD

Appointed: 1998

Mark Sands, MD
Department: Diagnostic Radiology
Vice Chair, Clinical Operations and Quality
Location: Cleveland Clinic Main Campus
Mail Code L10
9500 Euclid Avenue
Cleveland, OH 44195
Mark Sands, MD
Department: Transplantation Center
Location: Cleveland Clinic Main Campus
Mail Code L10
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Both Adults and Children & Adolescents

Biographical Sketch

Mark Jason Sands, MD, is Vice Chairman of Clinical Operations and Quality and Section Head of Interventional Radiology at the Imaging Institute, Cleveland Clinic. Dr. Sands obtained his MD degree from Northwestern University Medical School after completing a BS in medical science there.

Education & Fellowships

Fellowship - University of California San Francisco Medical Center
Interventional Radiology
San Francisco, CA USA
Residency - University of California San Francisco Medical Center
Diagnostic Radiology
San Francisco, CA USA
Internship - University of California San Francisco Medical Center
Internal Medicine
San Francisco, CA USA
Medical School - Northwestern University Feinberg School of Medicine
Chicago, IL USA


  • Diagnostic Radiology
  • Diagnostic Radiology- Vascular & Interventional Radiology

Specialty Interests

hepato-biliary disease and transplantation, vascular interventional radiology

Awards & Honors

Howard Hughes Medical Institute; National Institutes of Health Research Scholar, 1987-1988


  • Radiological Society of North America
  • Society of Interventional Radiology
  • American College of Radiology
  • Cardiovascular and Interventional Radiological Society of Europe

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/9/2014, Dr. Sands has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English